TITLE

Evaluation of the exhaled carbon monoxide levels in smokers with COPD

AUTHOR(S)
Chatkin, Gustavo; Chatkin, José Miguel; Aued, Gabriel; Petersen, Guilherme Oliveira; Thais Jeremias, Edna; Valladão Thiesen, Flávia
PUB. DATE
May 2010
SOURCE
Jornal Brasileiro de Pneumologia;may2010, Vol. 36 Issue 3, p332
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: To measure exhaled carbon monoxide (COex) levels in smokers with and without COPD. Methods: Smokers treated at outpatient clinics of São Lucas Hospital in the city of Porto Alegre, Brazil, between September of 2007 and March of 2009 were invited to participate in this study. The participants completed a questionnaire regarding demographic and epidemiologic characteristics and were submitted to spirometry, as well as to determination of COex and urinary cotinine levels. The participants were divided into two groups: those with COPD and those without COPD. Results: The study involved 294 smokers, of whom 174 (59.18%) had been diagnosed with COPD. All of the participants presented with urinary cotinine levels > 50 ng/mL. Smokers with COPD presented significantly higher median values for age and pack-years than did those without COPD (p < 0.001 and p = 0.026, respectively). No other statistically significant differences were found. When adjusted for gender, age at smoking onset, number of cigarettes/day and urinary cotinine level, the mean values of COex were higher, but not statistically so, in the COPD group than in the non-COPD group (17.8 ± 0.6 ppm and 16.6 ± 0.7 ppm, respectively; p = 0.200). The differences remained nonsignificant when plotted logarithmically. A wide dispersion of COex values was found when the participants were classified by FEV1 level (r = -0.06; p = 0.53) or by Global Initiative for Chronic Obstructive Lung Disease classification (r = 0.08; p = 0.34). The proportions of false-negative results for smoking were 18.4% and 6.7%, respectively, in the COPD and non-COPD groups (p = 0.007). Conclusions: Since COex values did not differ significantly between smokers with COPD and those without, there seem to be no major contraindications to their use in smokers with COPD.
ACCESSION #
53071407

 

Related Articles

  • Nonsmoking Buddies. Ryder, Gina // Psychology Today;Jan/Feb2009, Vol. 42 Issue 1, p19 

    The article discusses a study on smoking cessation published in the "New England Journal of Medicine." The study tracked a social network of 12,000 people over 32 years and shows that smokers tend to quit in clusters. Social influence is so powerful that quitting reduces the chance of a spouse...

  • Acceptability and feasibility of pulmonary rehabilitation for COPD: a community qualitative study. Moore, Lynda; Hogg, Lauren; White, Patrick // Primary Care Respiratory Journal;Dec2012, Vol. 21 Issue 4, p419 

    Background: Pulmonary rehabilitation (PR) is second in importance to smoking cessation treatment in the management of chronic obstructive pulmonary disease (COPD). Access to the service is limited and less than half of those referred complete the treatment. Aims: We assessed the obstacles to...

  • Skeletal muscle properties and fatigue resistance in relation to smoking history. Wüst, Rob C. I.; Morse, Christopher I.; de Haan, Arnold; Rittweger, Jörn; Jones, David A.; Degens, Hans // European Journal of Applied Physiology;Sep2008, Vol. 104 Issue 1, p103 

    Although smoking-related diseases, such as chronic obstructive pulmonary disease (COPD), are often accompanied by increased peripheral muscle fatigability, the extent to which this is a feature of the disease or a direct effect of smoking per se is not known. Skeletal muscle function was...

  • COPD.  // Thorax;Dec2001 Supp, Vol. 56, piii85 

    This article presents various studies related to chronic obstructive pulmonary diseases. Knowledge of a patient's smoking habit enables appropriate smoking advice to be given. However some smokers may deny their habit thus making counselling difficult. The breath carbon monoxide level monitor...

  • Doctors' Attitude Towards Current Smokers With Chronic Obstructive Pulmonary Disease and Its Impact on Delivering Smoking Cessation Advice. Winstanley, Laura; Daunt, Matthew; Macfarlane, James // Journal of Smoking Cessation;Dec2008, Vol. 3 Issue 2, p133 

    Objective: To explore the attitudes of hospital doctors towards current smokers with Chronic Obstructive Pulmonary Disease (COPD). Methods: We surveyed 184 hospital doctors of all grades regarding their attitudes to four patient scenarios including: current excess alcohol drinker, current smoker...

  • Chronic obstructive pulmonary disease. Crockett, Tony // Update;12/15/2005, Vol. 71 Issue 6, p14 

    This article focuses on the treatment of chronic obstructive pulmonary disease (COPD). COPD is a common illness that is incurable, progressive and. usually, ultimately fatal. It is characterised by airway obstruction that is irreversible or only partly reversible, alveolar damage and...

  • New model shows benefit of smoking cessation in COPD….  // PharmacoEconomics & Outcomes News;9/1/2012, Issue 661, p5 

    The article discusses research on the benefit of smoking cessation intervention in patient with mild chronic obstructive pulmonary disease (COPD). It references studies by P. Menn and colleagues, published in an issue of "Pharmacoeconomics" and I. B. Heredia-Pi and colleagues, published in the...

  • Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD. Kunz, Lisette I. Z; Lapperre, Thérèse S.; Snoeck-Stroband, Jiska B.; Budulac, Simona E.; Timens, Wim; van Wijngaarden, Simone; Schrumpf, Jasmijn A.; Rabe, Klaus F.; Postma, Dirkje S.; Sterk, Peter J.; Hiemstra, Pieter S. // Respiratory Research;Mar2011, Vol. 12 Issue 3, p1 

    Background: Macrophages have been implicated in the pathogenesis of COPD. M1 and M2 macrophages constitute subpopulations displaying pro- and anti-inflammatory properties. We hypothesized that smoking cessation affects macrophage heterogeneity in the lung of patients with COPD. Our aim was to...

  • Smoking Cessation Treatment and Outcomes Patterns Simulation: A New Framework for Evaluating the Potential Health and Economic Impact of Smoking Cessation Interventions. Getsios, Denis; Marton, Jenő; Revankar, Nikhil; Ward, Alexandra; Willke, Richard; Rublee, Dale; Ishak, K.; Xenakis, James // PharmacoEconomics;Sep2013, Vol. 31 Issue 9, p767 

    Background: Most existing models of smoking cessation treatments have considered a single quit attempt when modelling long-term outcomes. Objective: To develop a model to simulate smokers over their lifetimes accounting for multiple quit attempts and relapses which will allow for prediction of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics